One of the most exciting advances in biomedical research is the introduction of genome biology, which enables the researcher to gain a global view at high resolution. The invention of next generation (NextGen) sequencers greatly accelerates the integration of genome technology into other research fields and essentially brings the genome center capacity to individual research laboratories. NextGen sequencing has revolutionized the world of molecular biology, genetics, and genomics. The requested instrument will transform the way scientists from a broad range of disciplines conduct research to understand the molecular mechanisms of human diseases, including disease gene cloning, cancer, gene expression, splicing, development and differentiation, and epigenetics. We will apply the system to several different technologies, including: 1) identifying direct downstream targets of transcription factors by ChIP-Seq;2) performing transcriptome analysis of human tissues and model organisms by RNA-Seq;3) identifying and cloning human disease genes by whole genome and targeted capture deep sequencing;4) investigating alternative splicing and human diseases by splicing junction sequencing;and 5) examining affects of environment and nutrition on pregnancy, development, and disease by examining the epigenome through whole genome bisulfate sequencing and histone modifications. As the participating PIs all engage in both basic and clinical research including three who hold an M.D. degree, we believe the introduction of the single molecule sequencing (SMS) technology will have direct, strong, and immediate impact on many medically relevant fields.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Biomedical Research Support Shared Instrumentation Grants (S10)
Project #
1S10RR026550-01
Application #
7792997
Study Section
Special Emphasis Panel (ZRG1-GGG-E (31))
Program Officer
Birken, Steven
Project Start
2010-06-10
Project End
2011-09-09
Budget Start
2010-06-10
Budget End
2011-09-09
Support Year
1
Fiscal Year
2010
Total Cost
$500,000
Indirect Cost
Name
Baylor College of Medicine
Department
Genetics
Type
Schools of Medicine
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Dharmat, Rachayata; Liu, Wei; Ge, Zhongqi et al. (2017) IFT81 as a Candidate Gene for Nonsyndromic Retinal Degeneration. Invest Ophthalmol Vis Sci 58:2483-2490
Soens, Zachry T; Branch, Justin; Wu, Shijing et al. (2017) Leveraging splice-affecting variant predictors and a minigene validation system to identify Mendelian disease-causing variants among exon-captured variants of uncertain significance. Hum Mutat 38:1521-1533
Xu, Mingchu; Xie, Yajing Angela; Abouzeid, Hana et al. (2017) Mutations in the Spliceosome Component CWC27 Cause Retinal Degeneration with or without Additional Developmental Anomalies. Am J Hum Genet 100:592-604
Porto, Fernanda B O; Jones, Evan M; Branch, Justin et al. (2017) Molecular Screening of 43 Brazilian Families Diagnosed with Leber Congenital Amaurosis or Early-Onset Severe Retinal Dystrophy. Genes (Basel) 8:
Soens, Zachry T; Li, Yuanyuan; Zhao, Li et al. (2016) Hypomorphic mutations identified in the candidate Leber congenital amaurosis gene CLUAP1. Genet Med 18:1044-51
Coppieters, Frauke; Ascari, Giulia; Dannhausen, Katharina et al. (2016) Isolated and Syndromic Retinal Dystrophy Caused by Biallelic Mutations in RCBTB1, a Gene Implicated in Ubiquitination. Am J Hum Genet 99:470-80
Xu, Mingchu; Eblimit, Aiden; Wang, Jing et al. (2016) ADIPOR1 Is Mutated in Syndromic Retinitis Pigmentosa. Hum Mutat 37:246-9
Xu, Mingchu; Yamada, Takeyuki; Sun, Zixi et al. (2016) Mutations in POMGNT1 cause non-syndromic retinitis pigmentosa. Hum Mol Genet 25:1479-88
Tajiguli, Abulikemu; Xu, Mingchu; Fu, Qing et al. (2016) Next-generation sequencing-based molecular diagnosis of 12 inherited retinal disease probands of Uyghur ethnicity. Sci Rep 6:21384
Xu, Mingchu; Gelowani, Violet; Eblimit, Aiden et al. (2015) ATF6 Is Mutated in Early Onset Photoreceptor Degeneration With Macular Involvement. Invest Ophthalmol Vis Sci 56:3889-95

Showing the most recent 10 out of 26 publications